Abstract: An analysis is given of several biologically important processes, connected with the crystallization and kinetics of liophilization in aqueous physiological solutions. These are glass formation and vitrification of life, precipitation of slightly soluble salts and kinetics of crystallization in human urine, and the solution of CaOX concretions under the influence of biocompatible solubilizators, which are normal constituents of human urine. The problems investigated experimentally are treated in the framework of the capillary theory of nucleation and the Debye-Hückel model of ionic solutions.
INTRODUCTION
The development of life on Earth (and most probably in the Universe) is bound with aqueous solutions and connected with their physics and chemistry. The precipitation processes from aqueous physiological fluids are particularly significant in this respect: crystallization, that is, the nucleation and growth of crystals and, subsequently, their possible dissolution. Crystallization from solutions is thermodynamically determined by the solubility of crystallizing components and kinetically by fluidity and the processes of diffusion in the initial phase. Biological aqueous solutions are systems with complex composition. Thus, their thermodynamic properties are usually considered and calculated in the framework of the Debye-Hückel model of ionic solutions: accounting for the increased ionic strength, ψ, and for the presence of ionic complex-forming agents. On the basis of this model in the present paper, the solubilities of slightly soluble salts and the thermodynamic driving force, ∆µ, of their crystallization are determined and the thermodynamic barrier of crystalline nucleation is calculated. The coefficients of diffusion, D, in ionic solutions are estimated by a linear approximation especially for the case when the presence of viscosity-increasing constituents (such as glycerol) considerably decreases D, and thus decreases and even prevents crystallization. So the problems of glass formation and vitrification of life and of absolute anabiosis in aqueous solutions can be treated, as done here and in a series of preceding publications, in a quantitative way.
We developed a quantitative approach especially in analyzing the problems of solubility, precipitation, and possible liophilization of urinary calculi. Their formation and growth determine urolithiasis diseases in their various forms. The results of our experimental investigations show new ways of treating the problems of calcium oxalate (CaOX) formation and even of its dissolution in biological aqueous solutions.
In analyzing the problems of preventing crystallization in biological fluids, we develop a quantitative criterion for vitrification. It explains one of Nature's two main strategies for preserving life under severe conditions, even at temperatures approaching absolute zero.
by two reaction barriers. The first one, U, is kinetically based. The second one, W c , is thermodynamic in its nature and is given by the work, W c , to form a critical new phase cluster within the initial solution
Here, as usual, we have denoted the interface energy at the crystal nuclei/fluid interface with σ, V m is the molar volume of the newly formed phase and the dimensionless factor, φ, accounts for the activity of possible nucleation active substrates (according to definition, see [1, 2] , 0 ≤ φ ≤ 1). The thermodynamic driving force of the process of crystallization, ∆µ, is determined in our case by the equilibrium solubility, C o , of the crystallizing component, AB, and by its actual concentration, C, in the respective biological solution as [3, 4] 
Here, C o is the equilibrium activity of the component AB in solution, determined by, the ionic strength, ψ, of the biological fluid, and the equilibrium constants, K i , of complex-forming substances in solution.
In considering nucleation and growth in ionic solutions (as all biological solutions are) the determination of C o becomes the crux of the problem of proper definition and calculation of ∆µ. In refs. [3, 5, 6] we have described in detail the necessary steps in this calculation, using both a simple thermodynamic approach and also the concept of the ionic activity product, AP, conventionally employed in literature [7] in determining the activity coefficients of biological solutions. The activation energy, U o , in eq. 1 is connected with the diffusion coefficient, D AB , of the crystallizing (ionic) substance AB. It determines the impingement rate, β, of the A and B ions in the ambient phase solution to the growing crystal. In general, in aqueous biological solutions, D AB , and, U, can be taken to correspond to the respective values of the pure solvent (here, water) at the same temperature, T. However, when in the system are also present substances (like glycerol) considerably increasing its viscosity, the value of the diffusion coefficient
can be dramatically decreased. In such cases, as a first approximation it can be assumed [4] that the activation energy, U o,1 , in the solution is increased according to
where U o is the activation energy in the initial solution, U 1 , in the viscosity increasing liquid (e.g., glycerol), and x i is its molar part introduced.
With the above definition of ∆µ, the rate of growth, dC/dt, (or dissolution) of an AB crystal in the solution within a linear concentration gradient, ∂∆µ/∂z, is given by
In Nernst's approximation, it can be written (for a crystallite with the surface F) as
Here, δ is the thickness of Nernst's diffusion layer, and the kinetics of growth or dissolution is thus determined by
with an initial slope of
In this way, C o can be experimentally determined from dissolution experiments. This was the approach we employed [3, 5, 6] 
where K i and K j , are the respective equilibrium constants. Determining also the ion activity coefficient,
from the ionic strength of the solution (ψ = 1 /2 Σn k C k where k is taken over all ions in the system) the solubility, C o , of the electrolyte AB in eqs. 3 and 6 can be calculated. The result as it is derived in [3] reads
for the case when [A + ] and [B -] are in equivalent stiochiometric concentration in the solution and
when one of the ions is in excess of the other (eq. 10 gives the case when [A] >> [B]). In both eqs. 9 and 10, L o indicates the ion solubility product of AB for the temperature T in pure water, i.e., a value that is traditionally reported in reference literature. The case given with eq. 10 is of particular significance in biological aqueous solutions like urine: in considering the precipitation of calcium oxalate (CaC 2 O 4 ), it has to be accounted that usually [Ca 2+ ] >> (5 to 10) [C 2 O 4 2-]. In this way, the determination of C o is reduced to a problem of relatively simple calculations in terms of the thermodynamics of ionic solutions.
Thus, with the above outlined formalism we can treat quantitatively the kinetics of both crystallization and dissolution of the slightly soluble salt AB in a given physiologically important solution and, moreover, the vitrification of the whole biological system.
KINETICS OF VITRIFICATION
If a biological solution is quenched through the temperature range of possible crystallization with a cooling rate, q o , higher than a critical value, q ocrit , it vitrifies at a temperature, T g , where the time of molecular relaxation, τ, is compatible with its mean residence time of the system in the vicinity of T g . Thus, the condition for vitrification can be written [2] as
With a known molecular relation connecting τ with the coefficient of diffusion, D, (reading τ k = d o 2 /D, where d o corresponds to the mean molecular size in the system) we can write eq. 11, accounting for eqs. 4 in the form
where C 1 and C 2 are constants to a first approximation. In considering eq. 4b, this indicates that T g is linearly dependent on x 1 . Thus, it becomes evident that by increasing the mole fraction, x 1 , of the vis-cosity-increasing component (e.g., of glycerol) we decrease the velocity, q o , of cooling at which vitrification takes place. In this way, solutions can be obtained, vitrifying at experimentally accessible cooling rates, q o . Quenching biological liquids into liquid nitrogen in fact exploits the possibility indicated with eq. 12 in a qualitative way in vitrifying living cells (e.g., spermatozoids) into the state of absolute anabiosis. By using eq. 12, it is also possible to estimate the necessary percentage of viscosity-increasing substance in order to reach (at a given cooling rate, q o ) vitrification. Several examples in this respect give typical biological fluids, in which living cells are frozen-in (or "prepare" themselves to freeze-in) to a state of absolute anabiosis at different concentration, x 1 , of appropriate viscosity-increasing dopants. This is one of Nature's strategies for preserving life at severe under-coolings and possibly also for spreading it through the Universe (remember Arrhenius' ideas for cosmic transspermia).
KINETICS OF NUCLEATION OF CaOX IN URINE
From the structure of the thermodynamic barrier, W e (eq. 2), determined according to eq. 1 and the rate of nucleation it is evident that nucleation can be increased in three ways: by decreasing σ (introduction of surfactants [1, 2] ); by active insoluble substrates (crystallization cores [1, 2] ) with Φ << 1; and by increasing the supersaturation, ∆µ. The first two methods, it seems (together with the formation of viscosity-increasing substances in the body fluids) are also used by some organisms in severe environments (in the high latitudes of our planet) to survive at -40 to -50 °C: they induce massive fine-grained crystallization in their own body fluids and thus survive extreme cold in another state of absolute anabiosis. Thus, Nature employs techniques known from present-day technologies of induced nucleation in glass ceramic materials: introduction of surfactants, active nucleation centers, and/or viscosity modifiers in order to trigger and govern induced nucleation in biological liquids [2] .
However, in metastable systems, such as urine, nucleation has to be reduced or even eliminated. An electron microscopic investigation we performed to reveal the size distribution curves of CaOX crystallites formed in the urine of healthy persons and of persons chronically forming urinary stones showed great differences in both mean and modal size of the crystallites in the precipitates; in healthy persons, they were too small to sediment in the urinary tract. Our investigation showed that nucleation and especially growth rates were drastically suppressed in the urine of the "normals".
In considering nucleation in urine and risk factors for producing urolithiasis diseases (especially of CaOX crystallization [3, 7, 8] ) it turns out (against convential thinking governing literature for many years) that here the substantial way to suppress (or even to preclude) nucleation in the supersaturated liquid is to decrease supersaturation, ∆µ. This is achieved not so much by reducing the concentration of either Ca 2+ (which is a biologically impossible task) or of oxalic ions (its concentration can be reduced by appropriate diet) but by the presence of Ca 2+ or Ox 2-complexing ions [3, [7] [8] [9] [10] ]. An increasing ionic strength, ψ, also diminishes supersaturation according to eqs. 8 and 9.
In a thorough investigation [11, 12] , we determined the frequency distribution curves of both the concentration and the daily outputs of ionic strength factor determining ions (Na + , K + , Cl -, etc.) and of complex-forming ions (Mg 2+ , citrate anion, hippurate anion) in the urine of a relatively great number of both recurrent CaOX stone formers (indicated in Fig. 1 by SF, 318 persons) and of healthy controls (indicated in Fig. 1 by N, 80 persons) . The results thus obtained are summarized in Table 1 and in Fig.  1 as follows:
From the data presented, we calculated [11] [12] [13] the change in supersaturation, ∆µ, and risk factors of CaOX precipitation (and inhibition of nucleation) in both groups of investigated persons. In doing so (as also is qualitatively seen from Table 1), we observed that while ψ and the concentration of [Mg 2+ ] and citrate ions are substantially changed according to previous data [7, 8, 10, 14] (thus decreasing, also, ∆µ in healthy persons) another normally present constituent of human urine is dramatically reduced in recurrent CaOX stone formers, as seen from Table 1 and Fig. 1 . This is hippuric acid (C 6 H 5 CONH 2 ·COOH). Although rarely mentioned, it is in fact present in human urine in considerable concentrations, as known from literature and seen also from Table 1 . Its concentration in the urine of healthy persons as seen from Fig. 1 varies in broad limits and can be even more than ten times higher than in SF persons.
It is also known that hippurate acid is present in the urine of herbivorous mammals; for example, in the urine of horses (from whence its name is derived) it reaches concentrations up to 15 g/L. In this connection, it is also to be noted that herbivorous mammals, although having an enormous daily intake of oxalate ions (in the form of the water-soluble urine. This, as well as our physiological data summarized in Table 1 , seems to indicate that hippuric acid may be one of the essential (or even the main) regulator of CaOX supersaturation and growth in human urine. As previously reported [3, 11] , both inhibition possibilities of hippuric acid and the increased solubilities of CaOX crystals in both physiological solutions (with 0.3 M NaCl concentration, ensuring a "normal" ionic strength, ψ = 0.25) at various pH values, ranging from 2.7 to 7.0 and in artificial urine of conventional composition at pH = 5.2. These experiments gave as a first result a verification of a simple dependence, following directly from eq. 10 for the case A >> B (as it is in urine): that solubility, C o , should be linearly increasing with the increased concentration, C H , of the liophilizator
These measurements, described in more details in [3] also indicated that hippuric acid is a natural, possibly biologically compatible liophilizator of CaOX calculi in urine.
KINETICS OF DISSOLUTION OF CaOX
Our experiments on the dissolution of CaOX were performed in artificial urine and the physiological solution in an apparatus in which with a torsion balance the dissolution of CaOX concretions suspended on a Pt wire was continuously followed. The volume of the solution, stirred by an electromagnetic propeller, was 1500 cm 3 , and its temperature was 25°C; the Archimedean weight G(t) of the CaOX calculi samples (200-300 mg each) was measured with an accuracy of 0.5 mg, the duration of experiments was up to 60 days. In adding to the solution different concentrations of oxalate ions, the change of G(t) was followed at different supersaturations at different concentrations, C H , of hippuric acid. In Fig. 2 , two typical curves (at C H = 0 and at C H = 15 mMol/L) are given at zero supersaturation (C OX = 0) and at initially medium supersaturated urine. From the saturation plateaus and the initial slopes of each individual curve, the corresponding solubilities, C o , were determined according to eq. 6. From a biological standpoint and having in mind eventual medical applications, it is essential to note that it is possible thus to dissolve completely in 10-20 days in artificial urine at the "normal" super- The chemical and structural aspects of hippuric acid as a calcium complex-forming agent, its possibilities and limitations (at higher pH values) are discussed in detail in the literature [3, 11, 13, 15] . A quantitative comparison with conventionally known CaOX liophilizators (Na-EDTA) and supersaturation ion (Mg 2+ , citrate ions) is given in refs. [3, 11] ; in ref. [15] its CaOX-inhibiting properties are also reported, however, at physiologically inadmissibly high pH values. In refs. [3, 11] may also be found a discussion of possible applications of hippuric acid as natural biological agent in instrumental haemolysis in a way, similar to the usage of Complexon III (Na-EDTA) in present-day medicine. In refs. [11] [12] [13] are also described our experiments to increase concentration of hippuric acid in the organism and in urine by administering to patients benzoic acid derivatives, which, according to a well-known biochemical reaction, metabolize in the organism to an increased concentration of hippuric acid in urine.
SOLUBILITY AND DISSOLUTION OF CaOX IN OTHER BIOLOGICAL COMPLEXING AGENTS
The possible solubilizing and inhibiting effect of various oxy-acids (tartaric, malic, citric) on CaOX is known or anticipated in literature. In a recent publication [6] , we reported results on the increase in the solubility of CaOX under the influence of another simple amino acid, DL-lysine, which is also a normal constituent of human urine. We also obtained results similar to those with hippuric acid and lysine [5] with another constituent of human urine: α-ketoglutaric acid. Some of these are shown in Fig. 3 . In the experiments described [5, 6] , the formalism and the apparatus and methods described above were used. In considering the physiological effect of hippuric acid, it has to be noted that its concentration surpasses the concentration of the sum of all other amino acids in human urine. 
